| 标题 |
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple‐negative, early‐stage breast cancer (NeoCART): Results from a multicenter, randomized controlled, open‐label phase II trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:International Journal of Cancer 作者:Liulu Zhang; Zhi‐Yong Wu; Jie Li; Ying Lin; Zhenzhen Liu; et al 出版日期:2021-09-30 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)